Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 546, pseudogene (RN7SL546P) is a human pseudogene that resembles the gene for 7SL RNA, a key structural component of the signal recognition particle (SRP) involved in targeting proteins to the endoplasmic reticulum[3][5][7]. The 7SL pseudogene family is large in humans, with hundreds of similar loci dispersed in the genome, most of which are truncated and nonfunctional copies generated by retrotransposition of 7SL RNA[5][7]. Pseudogenes like RN7SL546P do not produce functional RNAs and are not expressed as part of the SRP complex, nor do they encode proteins[5][7][8]. While some pseudogenes can possess rare regulatory functions via RNA interference or epigenetic mechanisms, there is no evidence or functional annotation for RN7SL546P having such activity[2][4]. As a non-coding pseudogene, it is not considered a therapeutic target, biomarker, or disease gene, and there are no known drugs, clinical implications, or safety issues associated with it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 546, pseudogene (RN7SL546P).